Glenmark Pharma is set to declare its results for the third quarter of financial year 2012-13 on Tuesday. Analysts on an average expect profit after tax to grow 4 times year-on-year to Rs 181 crore in the quarter due to EBITDA expansion and one off income.
first published: Jan 29, 2013 12:40 pm
A collection of the most-viewed Moneycontrol videos.

Market Braces For Tough Session Amid AI-Led Global Tech Rout | RBI Policy Today | Opening Bell Live

Live: Nifty slips below 25,650 amid broad-based selloff; IT continues freefall | Closing Bell

Can Nifty Power Ahead For Fourth Day Despite Anthropic-Led Tech Jitters? | Opening Bell Live

Investing for a new era | LIVE conversation with Mukesh Ambani & Larry Fink
You are already a Moneycontrol Pro user.